Rockefeller Capital Management L.P. Neogenomics Inc Transaction History

Rockefeller Capital Management L.P.

$42.4 Billion
Q2 2025

A detailed history of Rockefeller Capital Management L.P. transactions in Neogenomics Inc stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 44,471 shares of NEO stock, worth $404,686. This represents 0.0% of its overall portfolio holdings.

Number of Shares

44,471

Previous 44,471 -0.0%

Holding current value

$404,686

Previous $325,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	SELL	$6.4 - $10.27 $39,449 - $63,304	-6,164 Reduced 12.17%	44,471 $325,000
Q1 2025 May 14, 2025	SELL	$9.09 - $18.61 $4,063 - $8,318	-447 Reduced 0.88%	50,635 $480,000
Q4 2024 Feb 13, 2025	BUY	$13.0 - $18.43 $218,803 - $310,195	16,831 Added 49.14%	51,082 $841,000
Q3 2024 Nov 14, 2024	SELL	$13.4 - $17.73 $3,041 - $4,024	-227 Reduced 0.66%	34,251 $505,000
Q2 2024 Aug 12, 2024	BUY	$13.01 - $15.77 $1,665 - $2,018	128 Added 0.37%	34,478 $478,000
Q1 2024 May 14, 2024	BUY	$14.06 - $16.79 $1,448 - $1,729	103 Added 0.3%	34,350 $539,000
Q4 2023 Feb 14, 2024	BUY	$11.67 - $20.73 $140 - $248	12 Added 0.04%	34,247 $554,000
Q3 2023 Nov 14, 2023	SELL	$12.15 - $17.85 $2,539 - $3,730	-209 Reduced 0.61%	34,235 $421,000
Q2 2023 Aug 14, 2023	SELL	$14.1 - $19.83 $7,035 - $9,895	-499 Reduced 1.43%	34,444 $553,000
Q1 2023 May 17, 2023	BUY	$9.09 - $19.45 $1,472 - $3,150	162 Added 0.47%	34,943 $607,000
Q4 2022 Mar 06, 2023	BUY	$6.45 - $12.07 $2,489 - $4,659	386 Added 1.12%	34,781 $160,000
Q3 2022 Nov 02, 2022	BUY	$7.86 - $12.91 $256,966 - $422,066	32,693 Added 1920.86%	34,395 $145,000
Q2 2022 Aug 12, 2022	BUY	$7.06 - $13.97 $8,592 - $17,001	1,217 Added 250.93%	1,702 $13,000
Q1 2022 May 13, 2022	SELL	$12.15 - $35.28 $7,253 - $21,062	-597 Reduced 55.18%	485 $5,000
Q4 2021 Feb 14, 2022	BUY	$30.49 - $48.49 $13,293 - $21,141	436 Added 67.49%	1,082 $36,000
Q3 2021 Nov 12, 2021	SELL	$41.66 - $52.52 $1,624 - $2,048	-39 Reduced 5.69%	646 $31,000
Q2 2021 Aug 10, 2021	BUY	$36.62 - $51.69 $6,518 - $9,200	178 Added 35.11%	685 $30,000
Q1 2021 May 11, 2021	BUY	$41.56 - $59.88 $3,117 - $4,491	75 Added 17.36%	507 $24,000
Q4 2020 Feb 12, 2021	BUY	$36.08 - $56.47 $14,107 - $22,079	391 Added 953.66%	432 $23,000
Q4 2019 Feb 07, 2020	BUY	$18.96 - $29.84 $777 - $1,223	41 New	41 $1,000

Others Institutions Holding NEO

# of Institutions

307

Shares Held

129M

Call Options Held

1.17M

Put Options Held

297K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.14B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.

Account

Rockefeller Capital Management L.P. Neogenomics Inc Transaction History